Pharmaron Beijing Co., Ltd. (SHE:300759)

China flag China · Delayed Price · Currency is CNY
35.75
+0.91 (2.61%)
Sep 30, 2025, 3:04 PM CST
2.61%
Market Cap60.45B
Revenue (ttm)13.11B
Net Income (ttm)1.38B
Shares Out1.77B
EPS (ttm)0.78
PE Ratio45.74
Forward PE30.82
Dividend0.20 (0.56%)
Ex-Dividend DateJul 4, 2025
Volume41,373,024
Average Volume56,641,502
Open34.78
Previous Close34.84
Day's Range34.61 - 36.09
52-Week Range20.47 - 37.63
Beta0.98
RSI62.24
Earnings DateOct 27, 2025

About Pharmaron Beijing

Pharmaron Beijing Co., Ltd., together with its subsidiaries, operates as a pharmaceutical research and development service platform in North America, Europe, the Mainland China, Asia, and internationally. It operates through five segments: Laboratory Services; Chemical and Formulation Process Development and Production Services; Clinical Research Services; Macromolecule and Cell and Gene Therapy Services; and Others. The company offers laboratory chemistry and biological science services, including small molecule chemical drugs, oligonucleotide... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2004
Employees 21,370
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300759
Full Company Profile

Financial Performance

In 2024, Pharmaron Beijing's revenue was 12.28 billion, an increase of 6.39% compared to the previous year's 11.54 billion. Earnings were 1.79 billion, an increase of 12.01%.

Financial Statements

News

There is no news available yet.